226 related articles for article (PubMed ID: 22986649)
1. The renin-angiotensin system in the pathophysiology of type 2 diabetes.
Goossens GH
Obes Facts; 2012; 5(4):611-24. PubMed ID: 22986649
[TBL] [Abstract][Full Text] [Related]
2. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
Ramalingam L; Menikdiwela K; LeMieux M; Dufour JM; Kaur G; Kalupahana N; Moustaid-Moussa N
Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1106-1114. PubMed ID: 27497523
[TBL] [Abstract][Full Text] [Related]
3. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
4. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
5. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.
Henriksen EJ
Am J Physiol Regul Integr Comp Physiol; 2007 Sep; 293(3):R974-80. PubMed ID: 17581838
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance.
Kalupahana NS; Moustaid-Moussa N
Obes Rev; 2012 Feb; 13(2):136-49. PubMed ID: 22034852
[TBL] [Abstract][Full Text] [Related]
7. Autophagy and Mitochondria in Obesity and Type 2 Diabetes.
Sarparanta J; García-Macia M; Singh R
Curr Diabetes Rev; 2017; 13(4):352-369. PubMed ID: 26900135
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.
Frigolet ME; Torres N; Tovar AR
J Nutr Biochem; 2013 Dec; 24(12):2003-15. PubMed ID: 24120291
[TBL] [Abstract][Full Text] [Related]
9. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
10. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system.
Cooper ME; Tikellis C; Thomas MC
J Hypertens Suppl; 2006 Mar; 24(1):S57-63. PubMed ID: 16601575
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome.
Leung PS; de Gasparo M
J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.
Scheen AJ
Diabetes Metab; 2004 Dec; 30(6):498-505. PubMed ID: 15671919
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus.
Leung PS; Carlsson PO
Pancreas; 2005 May; 30(4):293-8. PubMed ID: 15841036
[TBL] [Abstract][Full Text] [Related]
14. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
Scheen AJ
Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
[TBL] [Abstract][Full Text] [Related]
15. [Adipose tissue renin-angiotensin system in obese].
Yasue S; Ebihara K; Nakao K
Nihon Rinsho; 2012 Sep; 70(9):1550-5. PubMed ID: 23012802
[TBL] [Abstract][Full Text] [Related]
16. Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation.
Goossens GH; Jocken JW; Blaak EE; Schiffers PM; Saris WH; van Baak MA
Hypertension; 2007 Mar; 49(3):542-7. PubMed ID: 17224474
[TBL] [Abstract][Full Text] [Related]
17. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.
van der Zijl NJ; Moors CC; Goossens GH; Blaak EE; Diamant M
Diabetes Obes Metab; 2012 Jul; 14(7):586-95. PubMed ID: 22226145
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes.
Leung PS
Diabet Med; 2007 Feb; 24(2):110-6. PubMed ID: 17257271
[TBL] [Abstract][Full Text] [Related]
19. Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.
Jia D; Taguchi M; Otsuki M
Metabolism; 2005 May; 54(5):619-27. PubMed ID: 15877292
[TBL] [Abstract][Full Text] [Related]
20. The expanding role of oxidative stress, renin angiotensin system, and beta-cell dysfunction in the cardiometabolic syndrome and Type 2 diabetes mellitus.
Lastra G; Manrique C
Antioxid Redox Signal; 2007 Jul; 9(7):943-54. PubMed ID: 17508916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
